ARCHIVES

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

This article is from The Cancer Letter archive.

Vol. 24 No. 41 | October 30, 1998

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Okay Omnibus Prevention Program Announcement

January 24, 1992

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

Poll Finds Voters Support Doubling Of Research Funds.

November 3, 2000

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004